(Reuters) - U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of ...

A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

Moderna is one of the pharmaceutical companies best known for developing the messenger RNA vaccine against Covid-19.

The U.S. government awarded Moderna $590 million in January to advance the development of its bird flu vaccine ...

The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...

Nvidia reports better-than-expected fourth-quarter earnings as revenue jumps 78% on demand for the company’s ...

Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...

Moderna's reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...

Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: ...

U.S. health officials are reviewing the $590M deal for bird flu shots that the Biden administration awarded to Moderna (MRNA) in January, ...